These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10181565)

  • 1. Keeping patients with arthritis out of the hospital.
    Spiegel M
    Manag Care Interface; 1998 Jun; 11(6):81-5. PubMed ID: 10181565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of misoprostol in upper gastro-intestinal lesions in arthritic patients on non-steroidal anti-inflammatory drugs (NSAIDS)--an Indian experience.
    Bhatt CB; Pipalia DH; Naik SR; Tilve GH
    J Postgrad Med; 1988 Oct; 34(4):224-8. PubMed ID: 3151214
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"].
    Kellner H
    Krankenpfl J; 2004; 42(5-6):185. PubMed ID: 15527245
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs.
    Gøtzsche PC
    Clin Evid; 2002 Jun; (7):1063-70. PubMed ID: 12230727
    [No Abstract]   [Full Text] [Related]  

  • 5. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
    MMW Fortschr Med; 2010 May; 152(20):46-7. PubMed ID: 20552882
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A; Krahn M; Naglie G
    Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musculoskeletal disorders. Non-steroidal anti-inflammatory drugs.
    Gøtzsche PC
    Clin Evid; 2003 Jun; (9):1292-300. PubMed ID: 12967421
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs.
    Gøtzsche P
    Clin Evid; 2002 Dec; (8):1203-11. PubMed ID: 12603936
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
    Lanas A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal antiinflammatory drugs: benefit/risk evaluation in rheumatic diseases.
    Fenner H
    J Rheumatol Suppl; 1992 Jan; 32():98-9. PubMed ID: 1613741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
    Eisen GM; Goldstein JL; Hanna DB; Rublee DA
    Aliment Pharmacol Ther; 2005 Mar; 21(5):591-8. PubMed ID: 15740543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract.
    Lanas A
    Aliment Pharmacol Ther; 2004 Aug; 20(3):321-31. PubMed ID: 15274669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy.
    Walan A; Wahlqvist P
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S79-88. PubMed ID: 10379474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effective use of NSAIDs: issues pertinent to coxib use in managed care.
    Fendrick AM
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S529-41. PubMed ID: 12458822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
    Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
    Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper gastrointestinal complications: the causes, consequences, and clinical outcomes.
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S397-401. PubMed ID: 11570031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H; Bombardier C; Davis P; Russell AS;
    J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.